FibroGen Reports Financial Results for the First Quarter of 2016
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Needham Starts NeoVolta (NEOV) at Buy
FibroGen (FGEN) Tops Q1 EPS by 11c
May 9, 2016 4:45 PM EDTFibroGen (NASDAQ: FGEN) reported Q1 EPS of ($0.45), $0.11 better than the analyst estimate of ($0.56).
At March 31, 2016, FibroGen had $309.9 million of cash, cash equivalents, investments, receivables and restricted cash
For earnings history and earnings-related data on FibroGen (FGEN) click here.
... More